Adoptive Cell Therapy With Tumor-Infiltrating Lymphocytes: Emerging Data and Potential Applications

Download slides, review a text module, and read an expert commentary on adoptive cell therapy with tumor-infiltrating lymphocytes focusing on applications in melanoma.

Share

Program Content

Melanoma TIL Therapy
My Insights on the Latest Data on Tumor-Infiltrating Lymphocytes in Melanoma and Clinical Applications of TIL Therapy
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 14, 2023

Expires: February 13, 2024

View Activity
Melanoma TIL Therapy: Module
Adoptive Cell Therapy With Tumor-Infiltrating Lymphocytes: Emerging Data and Potential Applications
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: March 21, 2023

Expires: March 20, 2024

View Activity
Melanoma TIL Therapy: Slides
Adoptive Cell Therapy With Tumor-Infiltrating Lymphocytes: Emerging Data and Potential Applications
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 21, 2023

Expires: March 19, 2024

View Activity

Faculty

cover img faculity

Allison Betof Warner, MD, PhD

Assistant Professor of Medicine (Oncology)
Director, Melanoma Medical Oncology Program
Director, Solid Tumor Cellular Therapy 
Leader, Melanoma & Cutaneous Oncology Clinical Research Group
Stanford University School of Medicine
Stanford, California

cover img faculity

Amod A. Sarnaik, MD, FACS

Professor
Department of Oncologic Sciences/Cutaneous Oncology
Moffitt Cancer Center and University of South Florida
Senior Member
Cutaneous Oncology and Immunology
Moffitt Cancer Center and Research Institute
Tampa, Florida

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from

Iovance Biotherapeutics